1
|
Shoaib A, Kinnaird T, Curzen N, Ludman P, Belder MD, Rashid M, Kwok CS, Nolan J, Zaman A, Mamas M. P3583Outcomes following percutaneous coronary intervention in Non-ST-segment elevation myocardial infarction patients with previous coronary artery bypass grafts surgery. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.p3583] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- A Shoaib
- Keele University, Keele Cardiovascular Research Group, Institute for Primary Care and Health Sciences, Keele, United Kingdom
| | - T Kinnaird
- University Hospital of Wales, Cardiff, United Kingdom
| | - N Curzen
- University of Southampton, Southampton, United Kingdom
| | - P Ludman
- Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom
| | - M D Belder
- James Cook University Hospital, Middlesborough, United Kingdom
| | - M Rashid
- Keele University, Keele Cardiovascular Research Group, Institute for Primary Care and Health Sciences, Keele, United Kingdom
| | - C S Kwok
- Keele University, Keele Cardiovascular Research Group, Institute for Primary Care and Health Sciences, Keele, United Kingdom
| | - J Nolan
- Keele University, Keele Cardiovascular Research Group, Institute for Primary Care and Health Sciences, Keele, United Kingdom
| | - A Zaman
- Newcastle University, Newcastle upon Tyne, United Kingdom
| | - M Mamas
- Keele University, Keele Cardiovascular Research Group, Institute for Primary Care and Health Sciences, Keele, United Kingdom
| |
Collapse
|
2
|
Fioravanti F, Bertaina M, D'Ascenzo F, Bongiovanni F, Raposeiras-Roubin S, Abu-Assi E, Kinnaird T, Ariza-Sole A, Manzano-Fernandez S, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Rognoni A, Luscher TF. P3178Long vs. short dual antiplatelet therapy in ACS patients treated with prasugrel or ticagrelor and coronary revascularization: a propensity score analysis from the RENAMI registry. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.p3178] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- F Fioravanti
- Hospital Molinette of the University Hospital S. Giovanni Battista/City University Hosp of Health an, Department of Cardiology, Turin, Italy
| | - M Bertaina
- Hospital Molinette of the University Hospital S. Giovanni Battista/City University Hosp of Health an, Department of Cardiology, Turin, Italy
| | - F D'Ascenzo
- Hospital Molinette of the University Hospital S. Giovanni Battista/City University Hosp of Health an, Department of Cardiology, Turin, Italy
| | - F Bongiovanni
- Hospital Molinette of the University Hospital S. Giovanni Battista/City University Hosp of Health an, Department of Cardiology, Turin, Italy
| | | | - E Abu-Assi
- Hospital of Meixoeiro, Department of Cardiology, Vigo, Spain
| | - T Kinnaird
- University Hospital of Wales, Cardiology Department, Cardiff, United Kingdom
| | - A Ariza-Sole
- University Hospital of Bellvitge, Department of Cardiology, Barcelona, Spain
| | - S Manzano-Fernandez
- Hospital Clínico Univeristario Virgen de la Arrixaca, Department of Cardiology, Murcia, Spain
| | - C Templin
- Royal Brompton Hospital, Department of Cardiology, London, United Kingdom
| | - L Velicki
- Institute of cardiovascular Diseases, Vojvodina, Serbia
| | | | - E Cerrato
- University Hospital of Bellvitge, Department of Cardiology, Barcelona, Spain
| | - A Rognoni
- Hospital Maggiore Della Carita, Novara, Italy
| | - T F Luscher
- Royal Brompton Hospital, Department of Cardiology, London, United Kingdom
| | | |
Collapse
|
3
|
De Filippo O, Raposeiras-Roubin S, Gili S, Abu-Assi E, Kinnaird T, Ariza-Sole A, Manzano-Fernandez S, Templin C, Xanthopoulou I, Cerrato E, Rognoni A, Boccuzzi G, Montefusco A, Iniguez-Romo A, D'Ascenzo F. P5588REgistry of New Antiplatelet therapy in patients with acute Myocardial Infarction (RENAMI). Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy566.p5588] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- O De Filippo
- Hospital Molinette of the University Hospital S. Giovanni Battista/City University Hosp of Health an, Medical sciences, Turin, Italy
| | | | - S Gili
- Hospital Molinette of the University Hospital S. Giovanni Battista/City University Hosp of Health an, Medical sciences, Turin, Italy
| | - E Abu-Assi
- University Hospital Άlvaro Cunqueiro, Vigo, Spain
| | - T Kinnaird
- University Hospital of Wales, Cardiff, United Kingdom
| | - A Ariza-Sole
- University Hospital of Bellvitge, Barcelona, Spain
| | | | - C Templin
- University Heart Center, Zurich, Switzerland
| | | | - E Cerrato
- Degli Infermi Hospital, Rivoli, Italy
| | - A Rognoni
- Hospital Maggiore Della Carita, Novara, Italy
| | - G Boccuzzi
- San Giovanni Bosco Hospital of Turino, Turin, Italy
| | - A Montefusco
- Hospital Molinette of the University Hospital S. Giovanni Battista/City University Hosp of Health an, Medical sciences, Turin, Italy
| | | | - F D'Ascenzo
- Hospital Molinette of the University Hospital S. Giovanni Battista/City University Hosp of Health an, Medical sciences, Turin, Italy
| |
Collapse
|
4
|
Mohamed MO, Kinnaird T, Kwok CS, Rashid M, Anderson R, Martin G, Zaman A, Mamas MA. P4592Trends in prognosis and management of acute coronary syndromes using combined bleeding and ischaemic risk assessment - a retrospective analysis of MINAP data. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.p4592] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- M O Mohamed
- Keele University, Cardiovascular Research Group, Keele, United Kingdom
| | - T Kinnaird
- University Hospital of Wales, Cardiology, Cardiff, United Kingdom
| | - C S Kwok
- Keele University, Cardiovascular Research Group, Keele, United Kingdom
| | - M Rashid
- Keele University, Cardiovascular Research Group, Keele, United Kingdom
| | - R Anderson
- University Hospital of Wales, Cardiology, Cardiff, United Kingdom
| | - G Martin
- Manchester Academic Health Sciences Centre, Faculty of Biology, Medicine and Health, Farr Institute, Manchester, United Kingdom
| | - A Zaman
- Freeman Hospital, Cardiology, Newcastle upon Tyne, United Kingdom
| | - M A Mamas
- Keele University, Cardiovascular Research Group, Keele, United Kingdom
| |
Collapse
|
5
|
Hailan A, Khatun R, Khanji M, Battle C, Temblett P, Bodger O, Kinnaird T, Ionescu A. 32 Outcomes of PCI in mechanically-ventilated survivors of cardiac arrest: the view from wales. Heart 2016. [DOI: 10.1136/heartjnl-2016-309588.32] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
6
|
Chew DP, Kinnaird T, Casella G, Radke PW, Schiele F, Kaul U, Eijgelshoven I, Medic G, Bergman G. Relative efficacy of bivalirudin vs. heparin monotherapy in STEMI patients treated with primary percutaneous coronary intervention - a network meta-analysis. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht310.p5570] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
7
|
|
8
|
Abstract
BACKGROUND Managing gastrointestinal bleeding in a patient who has undergone recent percutaneous coronary intervention requires balancing the risk of stent thrombosis against further catastrophic bleeding. Stent thrombosis and severe gastrointestinal bleeding are life-threatening complications. AIMS To evaluate the risks of gastrointestinal bleeding in patients undergoing percutaneous coronary intervention in relation to anti-platelet therapy and to discuss management of gastrointestinal bleeding in these patients. DESIGN Review of published studies comparing anti-platelet and ulcer healing therapy. A review of the evidence surrounding the management of gastrointestinal bleeding and the need for anti-platelet therapy in patients undergoing percutaneous coronary intervention. FINDINGS Gastrointestinal bleeding is relatively common after percutaneous coronary intervention. In one study it complicated 2.3% of primary angioplasty, and these patients had a mortality of 10%. Recent registry data of patients experiencing a gastrointestinal bleed reported a mortality of 5.4%. Cessation of anti-platelet therapy carries a high risk of acute stent thrombosis, which has a high mortality. CONCLUSION Individualized specialist gastrointestinal and cardiological management of these patients in a high dependency environment is recommended. Supportive care and proton pump inhibition in combination with judicious use of anti-platelet therapy is likely to provide the best balance of risk.
Collapse
Affiliation(s)
- P Foley
- University of Birmingham, Good Hope Hospital, Rectory Road, Sutton Coldfield, UK
| | | | | | | |
Collapse
|
9
|
Kinnaird T, Stabile E, Zbinden S, Burnett MS, Epstein SE. Cardiovascular risk factors impair native collateral development and may impair efficacy of therapeutic interventions. Cardiovasc Res 2008; 78:257-64. [DOI: 10.1093/cvr/cvm116] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
10
|
Kinnaird T, Stabile E, Burnett MS, Shou M, Lee CW, Barr S, Fuchs S, Epstein SE. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 2004; 109:1543-9. [PMID: 15023891 DOI: 10.1161/01.cir.0000124062.31102.57] [Citation(s) in RCA: 957] [Impact Index Per Article: 47.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
BACKGROUND Bone marrow cell therapy is reported to contribute to collateral formation through cell incorporation into new or remodeling vessels. However, the possible role of a paracrine contribution to this effect is less well characterized. METHODS AND RESULTS Murine marrow-derived stromal cells (MSCs) were purified by magnetic bead separation of cultured bone marrow. The release of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), placental growth factor (PlGF), and monocyte chemoattractant protein-1 (MCP-1) was demonstrated by analysis of MSC conditioned media (MSC-CM). MSC-CM enhanced proliferation of endothelial cells and smooth muscle cells in a dose-dependent manner; anti-VEGF and anti-FGF antibodies only partly attenuated these effects. Balb/C mice (n=10) underwent distal femoral artery ligation, followed by adductor muscle injection of 1x10(6) MSCs 24 hours later. Compared with controls injected with media (n=10) or mature endothelial cells (n=8), distal limb perfusion improved, and mid-thigh conductance vessels increased in number and total cross-sectional area. MSC injection improved limb function and appearance, reduced the incidence of auto-amputation, and attenuated muscle atrophy and fibrosis. After injection, labeled MSCs were seen dispersed between muscle fibers but were not seen incorporated into mature collaterals. Injection of MSCs increased adductor muscle levels of bFGF and VEGF protein compared with controls. Finally, colocalization of VEGF and transplanted MSCs within adductor tissue was demonstrated. CONCLUSIONS MSCs secrete a wide array of arteriogenic cytokines. MSCs can contribute to collateral remodeling through paracrine mechanisms.
Collapse
MESH Headings
- Animals
- Cells, Cultured/metabolism
- Cells, Cultured/transplantation
- Chemokine CCL2/metabolism
- Collateral Circulation
- Culture Media, Conditioned/pharmacology
- Endothelial Cells/cytology
- Endothelial Cells/drug effects
- Endothelial Cells/metabolism
- Endothelium, Vascular/cytology
- Endothelium, Vascular/drug effects
- Fibroblast Growth Factor 2/metabolism
- Fibrosis
- Growth Substances/metabolism
- Hindlimb/blood supply
- Hypoxia-Inducible Factor 1, alpha Subunit
- Immunomagnetic Separation
- Injections, Intramuscular
- Ischemia/physiopathology
- Ischemia/therapy
- Mesenchymal Stem Cell Transplantation
- Mice
- Mice, Inbred BALB C
- Muscle, Skeletal/blood supply
- Muscle, Skeletal/pathology
- Muscle, Smooth, Vascular/cytology
- Muscle, Smooth, Vascular/drug effects
- Muscular Atrophy/etiology
- Muscular Atrophy/pathology
- Myocytes, Smooth Muscle/cytology
- Myocytes, Smooth Muscle/drug effects
- Myocytes, Smooth Muscle/metabolism
- Paracrine Communication
- Placenta Growth Factor
- Pregnancy Proteins/metabolism
- Stromal Cells/transplantation
- Transcription Factors/biosynthesis
- Transcription Factors/genetics
- Vascular Endothelial Growth Factor A/metabolism
Collapse
Affiliation(s)
- T Kinnaird
- Cardiovascular Research Institute, Washington, DC 20010, USA.
| | | | | | | | | | | | | | | |
Collapse
|
11
|
Abstract
BACKGROUND Bone marrow cell therapy is reported to contribute to collateral formation through cell incorporation into new or remodeling vessels. However, the possible role of a paracrine contribution to this effect is less well characterized. METHODS AND RESULTS Murine marrow-derived stromal cells (MSCs) were purified by magnetic bead separation of cultured bone marrow. The release of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), placental growth factor (PlGF), and monocyte chemoattractant protein-1 (MCP-1) was demonstrated by analysis of MSC conditioned media (MSC-CM). MSC-CM enhanced proliferation of endothelial cells and smooth muscle cells in a dose-dependent manner; anti-VEGF and anti-FGF antibodies only partly attenuated these effects. Balb/C mice (n=10) underwent distal femoral artery ligation, followed by adductor muscle injection of 1x10(6) MSCs 24 hours later. Compared with controls injected with media (n=10) or mature endothelial cells (n=8), distal limb perfusion improved, and mid-thigh conductance vessels increased in number and total cross-sectional area. MSC injection improved limb function and appearance, reduced the incidence of auto-amputation, and attenuated muscle atrophy and fibrosis. After injection, labeled MSCs were seen dispersed between muscle fibers but were not seen incorporated into mature collaterals. Injection of MSCs increased adductor muscle levels of bFGF and VEGF protein compared with controls. Finally, colocalization of VEGF and transplanted MSCs within adductor tissue was demonstrated. CONCLUSIONS MSCs secrete a wide array of arteriogenic cytokines. MSCs can contribute to collateral remodeling through paracrine mechanisms.
Collapse
MESH Headings
- Animals
- Cells, Cultured/metabolism
- Cells, Cultured/transplantation
- Chemokine CCL2/metabolism
- Collateral Circulation
- Culture Media, Conditioned/pharmacology
- Endothelial Cells/cytology
- Endothelial Cells/drug effects
- Endothelial Cells/metabolism
- Endothelium, Vascular/cytology
- Endothelium, Vascular/drug effects
- Fibroblast Growth Factor 2/metabolism
- Fibrosis
- Growth Substances/metabolism
- Hindlimb/blood supply
- Hypoxia-Inducible Factor 1, alpha Subunit
- Immunomagnetic Separation
- Injections, Intramuscular
- Ischemia/physiopathology
- Ischemia/therapy
- Mesenchymal Stem Cell Transplantation
- Mice
- Mice, Inbred BALB C
- Muscle, Skeletal/blood supply
- Muscle, Skeletal/pathology
- Muscle, Smooth, Vascular/cytology
- Muscle, Smooth, Vascular/drug effects
- Muscular Atrophy/etiology
- Muscular Atrophy/pathology
- Myocytes, Smooth Muscle/cytology
- Myocytes, Smooth Muscle/drug effects
- Myocytes, Smooth Muscle/metabolism
- Paracrine Communication
- Placenta Growth Factor
- Pregnancy Proteins/metabolism
- Stromal Cells/transplantation
- Transcription Factors/biosynthesis
- Transcription Factors/genetics
- Vascular Endothelial Growth Factor A/metabolism
Collapse
Affiliation(s)
- T Kinnaird
- Cardiovascular Research Institute, Washington, DC 20010, USA.
| | | | | | | | | | | | | | | |
Collapse
|
12
|
Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, Fuchs S, Epstein SE. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 2004; 94:678-85. [PMID: 14739163 DOI: 10.1161/01.res.0000118601.37875.ac] [Citation(s) in RCA: 1011] [Impact Index Per Article: 50.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
We recently demonstrated that marrow stromal cells (MSCs) augment collateral remodeling through release of several cytokines such as VEGF and bFGF rather than via cell incorporation into new or remodeling vessels. The present study was designed to characterize the full spectrum of cytokine genes expressed by MSCs and to further examine the role of paracrine mechanisms that underpin their therapeutic potential. Normal human MSCs were cultured under normoxic or hypoxic conditions for 72 hours. The gene expression profile of the cells was determined using Affymetrix GeneChips representing 12 000 genes. A wide array of arteriogenic cytokine genes were expressed at baseline, and several were induced >1.5-fold by hypoxic stress. The gene array data were confirmed using ELISA assays and immunoblotting of the MSC conditioned media (MSC(CM)). MSC(CM) promoted in vitro proliferation and migration of endothelial cells in a dose-dependent manner; anti-VEGF and anti-FGF antibodies only partially attenuated these effects. Similarly, MSC(CM) promoted smooth muscle cell proliferation and migration in a dose-dependent manner. Using a murine hindlimb ischemia model, murine MSC(CM) enhanced collateral flow recovery and remodeling, improved limb function, reduced the incidence of autoamputation, and attenuated muscle atrophy compared with control media. These data indicate that paracrine signaling is an important mediator of bone marrow cell therapy in tissue ischemia, and that cell incorporation into vessels is not a prerequisite for their effects.
Collapse
MESH Headings
- Adult
- Animals
- Blood Vessels/cytology
- Blood Vessels/growth & development
- Bone Marrow Cells/physiology
- Cell Division/drug effects
- Cell Hypoxia
- Cell Movement/drug effects
- Cells, Cultured/drug effects
- Cells, Cultured/metabolism
- Collateral Circulation/drug effects
- Collateral Circulation/physiology
- Culture Media, Conditioned/pharmacology
- Cytokines/biosynthesis
- Cytokines/genetics
- Cytokines/metabolism
- Cytokines/physiology
- Cytokines/therapeutic use
- Dose-Response Relationship, Drug
- Endothelial Cells/drug effects
- Endothelium, Vascular/cytology
- Female
- Gene Expression Profiling
- Gene Expression Regulation
- Humans
- Ischemia/drug therapy
- Ischemia/physiopathology
- Mice
- Mice, Inbred BALB C
- Muscle, Smooth, Vascular/cytology
- Muscle, Smooth, Vascular/drug effects
- Muscular Atrophy/etiology
- Muscular Atrophy/prevention & control
- Myocytes, Smooth Muscle/drug effects
- Paracrine Communication
- Stromal Cells/cytology
- Stromal Cells/metabolism
Collapse
Affiliation(s)
- T Kinnaird
- Cardiovascular Research Institute, Washington Hospital Center, Washington, DC 20010, USA.
| | | | | | | | | | | | | |
Collapse
|
13
|
Stabile E, Kinnaird T, Fuchs S. Troponin in acute coronary syndrome patients. The interventional cardiologist perspective. Minerva Cardioangiol 2002; 50:637-42. [PMID: 12473983] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/28/2023]
Abstract
Troponin measurement has now become an integral part of the assessment of patients with acute coronary syndromes (ACS). Obtaining troponin levels have been used effectively as a diagnostic tool with superior sensitivity and specificity compared to creatine kinase MB fraction in identifying high-risk ACS patients. The adverse prognosis of these high-risk patients can be modified by more aggressive treatment strategy including antiplatelet and antithrombotic therapy accompanied, if feasible, by early percutaneous intervention. The current review summarizes available data on troponin measurement as a clinical tool for tailoring therapeutic strategy in non-ST elevation ACS patients. In addition, the data on the potential predictive value of postintervention troponin levels is discussed.
Collapse
Affiliation(s)
- E Stabile
- Cardiovascular Research Institute, Cardiac Catheterization Laboratories, Washington Hospital Center, Washington, DC 20010, USA
| | | | | |
Collapse
|
14
|
Oslizlok P, Duff D, Denham B, Penny WJ, Banning AP, Groves PH, Brewer L, Lewis MJ, Cheadle H, Crawford N, Kearney PP, Starkey IR, Fort S, McMurray JV, Shaw TR, Sutherland GR, Hennessy T, McCann H, Sugrue D, Foley DP, Melkert R, Keane D, Serruys PW, Vaughan CJ, O’Connell DP, McDonald D, Blake S, Garadah T, Mehana N, King G, Gearty G, Crean P, Walsh M, Galvin J, Codd MB, McCann HA, Sugrue DD, Gaylani NE, Weston C, Thomas A, Davies L, Tovey J, Musumeci F, Singh HP, Hargrove M, Fennell W, Aherne T, Crowley JJ, Hassanein H, Shapiro LM, McCrissican D, Morton P, O’Donnell AF, McBrinn S, McCarthy J, McCarthy D, Neligan MC, McGovern E, Herity NA, Allen JD, Silke B, Adgey AAJ, Johnston PW, Anderson J, McIlroy RL, Dunn HM, Nikookam K, McNeill AJ, Foley P, Foley D, de Jaegere P, Serruys P, O’Callaghan D, Vela J, Maguire M, Horgan J, Graham ANJ, Wilson CM, Hood JM, D’SA AABB, Khan MM, McClements B, Dalzell G, Campbell NPS, Webb SW, Shandall A, Buchalter MB, Northbridge DB, McMurray J, Dargie HJ, Sullivan PA, McLoughlin M, Varma MPS, Charleton P, Turkington E, Rusk RA, Richardson SG, Hale A, O’Shea JC, Murphy MB, Diamond P, McAleer B, Davies S, Kinnaird T, Duly E, McKenna CJ, Codd M, McGee HM, Browne C, Horgan JH. Irish cardiac society Proceedings of Annual General Meeting held 4th/5th November, 1994. Ir J Med Sci 1995. [DOI: 10.1007/bf02968121] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|